These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3691148)

  • 1. Crystallization in gel matrices: a new experimental model of calcium stone formation.
    Achilles W
    Contrib Nephrol; 1987; 58():59-64. PubMed ID: 3691148
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on urinary calcium ion activity in urolithiasis, 2. The relationship to calcium oxalate crystal formation and the effects of magnesium and citrate].
    Morimoto S
    Nihon Hinyokika Gakkai Zasshi; 1985 Jul; 76(7):998-1005. PubMed ID: 4079203
    [No Abstract]   [Full Text] [Related]  

  • 3. Calcium citrate: reduced propensity for the crystallization of calcium oxalate in urine resulting from induced hypercalciuria of calcium supplementation.
    Harvey JA; Zobitz MM; Pak CY
    J Clin Endocrinol Metab; 1985 Dec; 61(6):1223-5. PubMed ID: 4055988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orthophosphate and other phosphate compounds in relation to stone formation.
    Fleisch H
    Adv Exp Med Biol; 1978; 103():203-16. PubMed ID: 213950
    [No Abstract]   [Full Text] [Related]  

  • 5. [Estimation of 24-h excretion of some promotors and inhibitors of crystallization and degree of urine saturation with calcium oxalate in calcium urinary calculi].
    Boruczkowska A
    Pol Arch Med Wewn; 1994 Oct; 92(4):289-98. PubMed ID: 7854956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for urinary calcium oxalate crystals as revealed by their specific enzymatic assay.
    Hallson PC; Rose GA
    Br J Urol; 1989 Nov; 64(5):451-7. PubMed ID: 2611612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in urinary composition of calcium oxalate stone formers.
    Rahman B; Rahman MA
    Biomed Pharmacother; 1986; 40(3):108-10. PubMed ID: 3742009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of pH on the risk of calcium oxalate crystallization in urine.
    Berg C; Tiselius HG
    Eur Urol; 1986; 12(1):59-61. PubMed ID: 3948899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formation of spherulites of calcium phosphate and crystallization of calcium oxalate in gel in a new experimental model of urinary stone formation.
    Achilles W; Jöckel U; Schaper A; Burk M; Ulshöfer B; Riedmiller H
    Investig Urol (Berl); 1994; 5():218-21. PubMed ID: 7719309
    [No Abstract]   [Full Text] [Related]  

  • 10. Detection of crystallization inhibitory activity of whole urine with a gel model.
    Li MK; Shum DK; Choi S
    Urol Res; 1987; 15(2):75-7. PubMed ID: 3590432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study on metastable limit of calcium oxalate in whole urine using an aggregometer].
    Ebisuno S; Yoshida T; Yasukawa S; Fukatani T; Minakata S; Uehara M; Morimoto S; Ohkawa T
    Nihon Hinyokika Gakkai Zasshi; 1988 Oct; 79(10):1646-52. PubMed ID: 3251098
    [No Abstract]   [Full Text] [Related]  

  • 12. Some acid-base balance-dependent urinary parameters and calcium-binding anions in stone formers.
    Vogel E; Leskovar P; Schütz W
    Eur Urol; 1984; 10(4):254-9. PubMed ID: 6479200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of pH on the urinary inhibition of calcium oxalate crystal growth.
    Tiselius HG
    Br J Urol; 1981 Oct; 53(5):470-4. PubMed ID: 6793122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary inhibitory activity of calcium oxalate monohydrate crystal growth in stone-formers & non stone-formers.
    Sidhu H; Vaidyanathan S; Wangoo D; Rattan V; Thind SK; Nath R; Malakondaiah GC; Tandon SP
    Indian J Med Res; 1987 Oct; 86():500-5. PubMed ID: 3443483
    [No Abstract]   [Full Text] [Related]  

  • 15. [Alkalinizing treatment as a preventative of recurrent calcium oxalate lithiasis].
    Cifuentes Delatte L
    Arch Esp Urol; 1991 Oct; 44(8):903-10. PubMed ID: 1796852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Idiopathic calcium oxalate urinary lithiasis: usefulness of Parks' and Tiselius' indices in the evaluation of the risk of stone formation.
    Robert M; Roux JO; Boularan AM; Bourelly F; Monnier L; Grasset D
    Urol Int; 1995; 55(2):88-92. PubMed ID: 8533202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Influence of urinary citrate levels on spontaneous calcium oxalate dihydrate crystalluria].
    Hassani MA; Hennequin C; Lacour B; Daudon M
    Prog Urol; 2005 Sep; 15(4):650-5. PubMed ID: 16459680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Indicators of the risk of calcium oxalate urinary calculi: comparative study of the Parks' and Tiselius' indices, urinary citrate/calciuria ratio, and morning crystalluria].
    Robert M; Boularan AM; Guiter J; Monnier L
    Prog Urol; 1996 Apr; 6(2):264-8. PubMed ID: 8777421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrasting effects of potassium citrate and sodium citrate therapies on urinary chemistries and crystallization of stone-forming salts.
    Sakhaee K; Nicar M; Hill K; Pak CY
    Kidney Int; 1983 Sep; 24(3):348-52. PubMed ID: 6645208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of citrate on the different phases of calcium oxalate crystallization.
    Tiselius HG; Berg C; Fornander AM; Nilsson MA
    Scanning Microsc; 1993 Mar; 7(1):381-9; discussion 389-90. PubMed ID: 8316807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.